A detailed history of Saturn V Capital Management LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Saturn V Capital Management LLC holds 1,093,677 shares of CELC stock, worth $14.7 Million. This represents 5.58% of its overall portfolio holdings.

Number of Shares
1,093,677
Previous 1,063,783 2.81%
Holding current value
$14.7 Million
Previous $13.9 Billion 20.6%
% of portfolio
5.58%
Previous 5.45%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$8.62 - $13.62 $257,686 - $407,156
29,894 Added 2.81%
1,093,677 $11.1 Billion
Q4 2024

Feb 14, 2025

BUY
$12.0 - $16.35 $1.41 Million - $1.92 Million
117,448 Added 12.41%
1,063,783 $13.9 Billion
Q3 2024

Nov 14, 2024

BUY
$13.98 - $19.15 $2.59 Million - $3.55 Million
185,394 Added 24.36%
946,335 $14.1 Billion
Q2 2024

Aug 14, 2024

BUY
$14.1 - $20.78 $10.7 Million - $15.8 Million
760,941 New
760,941 $12.5 Billion

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $200M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.